Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CTI BioPharma (CTIC) stock

Learn how to easily invest in CTI BioPharma stock.

CTI BioPharma Corp
NASDAQ: CTIC - USD
BIOTECHNOLOGY
$2.41
+$0.01 (+0.42%)

CTI BioPharma Corp is a biotechnology business based in the US. CTI BioPharma shares (CTIC) are listed on the NASDAQ and all prices are listed in US Dollars. CTI BioPharma employs 22 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in CTI BioPharma

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CTIC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CTI BioPharma stock price (NASDAQ: CTIC)

Use our graph to track the performance of CTIC stocks over time.

CTI BioPharma shares at a glance

Information last updated 2021-07-23.
Latest market close$2.39
52-week range$0.96 - $4.03
50-day moving average $2.41
200-day moving average $2.78
Wall St. target price$7.34
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.62

Buy CTI BioPharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CTI BioPharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CTI BioPharma price performance over time

Historical closes compared with the close of $2.39 from 2021-05-28

1 week (2021-07-14) N/A
1 month (2021-06-25) 2.14%
3 months (2021-04-21) N/A
6 months (2021-01-21) N/A
1 year (2020-07-21) N/A
2 years (2019-07-21) N/A
3 years (2018-07-21) N/A
5 years (2016-07-21) N/A

CTI BioPharma financials

Gross profit TTM $3.3 million
Return on assets TTM -50.57%
Return on equity TTM -124.15%
Profit margin 0%
Book value $0.35
Market capitalisation $224.8 million

TTM: trailing 12 months

Shorting CTI BioPharma shares

There are currently 2.0 million CTI BioPharma shares held short by investors – that's known as CTI BioPharma's "short interest". This figure is 0% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting CTI BioPharma shares can be evaluated.

CTI BioPharma's "short interest ratio" (SIR)

CTI BioPharma's "short interest ratio" (SIR) is the quantity of CTI BioPharma shares currently shorted divided by the average quantity of CTI BioPharma shares traded daily (recently around 679341.41414141). CTI BioPharma's SIR currently stands at 2.97. In other words for every 100,000 CTI BioPharma shares traded daily on the market, roughly 2970 shares are currently held short.

However CTI BioPharma's short interest can also be evaluated against the total number of CTI BioPharma shares, or, against the total number of tradable CTI BioPharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CTI BioPharma's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CTI BioPharma shares in existence, roughly 20 shares are currently held short) or 0.029% of the tradable shares (for every 100,000 tradable CTI BioPharma shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CTI BioPharma.

Find out more about how you can short CTI BioPharma stock.

CTI BioPharma share dividends

We're not expecting CTI BioPharma to pay a dividend over the next 12 months.

Have CTI BioPharma's shares ever split?

CTI BioPharma's shares were split on a 1:10 basis on 2 January 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CTI BioPharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for CTI BioPharma shares which in turn could have impacted CTI BioPharma's share price.

CTI BioPharma share price volatility

Over the last 12 months, CTI BioPharma's shares have ranged in value from as little as $0.9629 up to $4.03. A popular way to gauge a stock's volatility is its "beta".

CTIC.US volatility(beta: 0.71)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CTI BioPharma's is 0.7078. This would suggest that CTI BioPharma's shares are less volatile than average (for this exchange).

CTI BioPharma overview

CTI BioPharma Corp. , a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. ; S*BIO Pte Ltd. ; and Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc.

Stocks similar to CTI BioPharma

Frequently asked questions

What percentage of CTI BioPharma is owned by insiders or institutions?
Currently 0.217% of CTI BioPharma shares are held by insiders and 51.309% by institutions.
How many people work for CTI BioPharma?
Latest data suggests 22 work at CTI BioPharma.
When does the fiscal year end for CTI BioPharma?
CTI BioPharma's fiscal year ends in December.
Where is CTI BioPharma based?
CTI BioPharma's address is: 3101 Western Avenue, Seattle, WA, United States, 98121
What is CTI BioPharma's ISIN number?
CTI BioPharma's international securities identification number is: US12648L6011
What is CTI BioPharma's CUSIP number?
CTI BioPharma's Committee on Uniform Securities Identification Procedures number is: 12648L106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site